Continual Online Learning Series

ONLINE EXCLUSIVE

Molecular Profiling and Decision Making
in Breast Cancer:
A Continual Online Learning Series

Four programs addressing the use of molecular profiling
and decision making in breast cancer

Program 1

Treatment Decision Tools

Featured Faculty

Hope S. Rugo, MD; Eleftherios Mamounas, MD

Moderator: Debu Tripathy, MD

TAKE THIS ACTIVITY

Program 2

Applications in the Clinical Setting

Featured Faculty

David M. Euhus, MD, FACS; Stephen Johnston, MD, PhD

Moderator: Debu Tripathy, MD

TAKE THIS ACTIVITY

Program 3

Defining Candidates for Gene Profiling

Featured Faculty

Charles Perou, PhD
Lori Goldstein, MD
Matthew Ellis, MB BChir, FRCP

Moderator: Debu Tripathy, MD

TAKE THIS ACTIVITY

Program 4

Clinical and Molecular Prognostic Information: Addressing Discordant Results

Featured Faculty

Hope S. Rugo, MD; Eleftherios Mamounas, MD; David M. Euhus, MD, FACS; Stephen Johnston, MD, PhD; Charles Perou, PhD; Lori Goldstein, MD

Moderator: Debu Tripathy, MD

TAKE THIS ACTIVITY

Description

This continual online learning series consists of four programs addressing the use of molecular profiling and decision making in breast cancer. Rapid changes in the understanding of the molecular diversity of breast and other cancers has been enabled by new gene profiling technology. Gene signatures using defined platforms and algorithms can provide more accurate estimations of long term prognosis of early stage breast cancer compared to standard clinical and pathological indices. Expert researchers and clinicians will offer didactic overviews of the scientific basis and technology, reviews of landmark clinical studies, case-based learning opportunities and a panel discussion.

Summary and Purpose

Molecular Profiling and Decision Making in Breast Cancer: A Continual On-Line Learning Series is designed to provide sustained on-line learning for oncologists and other health care providers involved in the diagnosis and treatment of breast cancer. In the area of molecular profiling the recent emergence of commercially available gene profiling tools, coupled with the variable degree of benefit balanced against the short and long term effects of chemotherapy creates a pressing educational need for clinicians.

Target Audience

Medical and surgical oncologists who counsel patients on therapeutic decisions following surgery for early stage breast cancer. Other physicians such as radiation oncologists, primary physicians, and healthcare providers such as nurses, pharmacists and others who care for patients with breast cancer.

Learning Objectives

At the conclusion of this activity, you should be able to:

  • Discuss molecular heterogeneity of breast cancer and the relationship of gene-based molecular profiles to clinical outcomes
  • Compare and contrast different molecular profiling assays and their ability to provide prognosis of patients with early stage breast cancer
  • Apply molecular profiling in patient decision-making in defined clinical scenarios
  • Describe the advantages and limitations of different molecular profiling assays and indications for participation in clinical trials designed to further evaluate their utility in decision-making for early stage breast cancer